What's Going On With Moderna Shares?

Shares of vaccine companies, including Moderna Inc MRNA, are trading higher amid COVID-19 concerns due to rising cases in China.

Rising COVID-19 cases in China's capital Beijing and Shanghai, where enforcement of a strict "zero-COVID" policy is ongoing, have drawn global attention. 

The world's second-largest economy has been struggling to completely stamp out the pandemic as traders and investors weigh increasing infections in the region.

See Also: Why Axsome Therapeutics Stock Is Falling Today

Moderna’s mRNA technology was rapidly validated with its COVID-19 vaccine, which was authorized in the United States in December 2020.

According to data from Benzinga Pro, Moderna has a 52-week high of $497.49 and a 52-week low of $122.01.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: MoversTrading IdeasSectorwhy it's moving
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!